Cross-presentation and genome-wide screening reveal candidate T cells antigens for a herpes simplex virus type 1 vaccine.
Jing L, Haas J, Chong TM, Bruckner JJ, Dann GC, Dong L, Marshak JO, McClurkan CL, Yamamoto TN, Bailer SM, Laing KJ, Wald A, Verjans GM, Koelle DM.
Jing L, et al. Among authors: koelle dm.
J Clin Invest. 2012 Feb;122(2):654-73. doi: 10.1172/JCI60556. Epub 2012 Jan 3.
J Clin Invest. 2012.
PMID: 22214845
Free PMC article.